EUVIMEDEUVIMED entdecken
Crossref

Design Strategy of Antibody Pairs for Biepitopic Antigen‐Templated Chemical Reaction Depending on the Tertiary Structure of the Antigen

Kentaro Nishiyama iD, Hiroki Akiba iD, Yuya Tsutsui, Haruhiko Kamada, Hiroaki Ohno iD

Chemistry – A European Journal · 2025

DOI: 10.1002/chem.202501803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Kentaro Nishiyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan. Hauptthemen laut MEDLINE: Antigens, Erb-b2 Receptor Tyrosine Kinases, Epitopes, Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Japan Science and Technology Agency, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Template reactions are site‐specific, rapid chemical reactions driven by high‐affinity biomolecular interactions. Recently, our group reported a reaction triggered by antigen–antibody interactions, named the biepitopic antigen‐templated chemical reaction (BATER). In BATER, reactive groups are conjugated to two antibodies recognizing different epitopes of the same antigen. Upon antigen binding, these groups are brought into proximity, enabling rapid reaction. However, the report was limited to tumor necrosis factor receptor 2, and its applicability to other targets remained unclear. In this study, we report strategies to expand BATER to antigens with diverse structural characteristics. Three distinct approaches were applied: (1) epitope selection leveraging structural flexibility of the antigen; (2) the use of protein domains as spacers; and (3) the use of small engineered antibodies. These strategies enabled BATER with CD30 and human epidermal growth factor receptor 2, demonstrating its broad applicability. The expanded range of antigens targeted by BATER will pave the way for potential applications in chemical biology, diagnosis, and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntigensErb-b2 Receptor Tyrosine KinasesEpitopesAntibodiesHumansAntigen-Antibody Reactions

Stichwörter der Autor:innen

antibodiesclick reactionconjugation chemistryproximity‐induced reactionstemplate reactions

Substanzen

AntigensErb-b2 Receptor Tyrosine KinasesEpitopesAntibodiesERBB2 protein, human

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
  • National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki City, Osaka, 567-0085, Japan.

ORCID-Profile: Kentaro Nishiyama, Hiroki Akiba, Hiroaki Ohno

Förderung

  • Japan Science and Technology Agency
  • Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Nishiyama, K., Akiba, H., Tsutsui, Y., Kamada, H., & Ohno, H. (2025). Design Strategy of Antibody Pairs for Biepitopic Antigen‐Templated Chemical Reaction Depending on the Tertiary Structure of the Antigen. Chemistry – A European Journal. https://doi.org/10.1002/chem.202501803

Vancouver

Nishiyama K, Akiba H, Tsutsui Y, Kamada H, Ohno H. Design Strategy of Antibody Pairs for Biepitopic Antigen‐Templated Chemical Reaction Depending on the Tertiary Structure of the Antigen. Chemistry – A European Journal. 2025. doi:10.1002/chem.202501803

BibTeX
@article{Nishiyama2025,
  author = {Nishiyama, Kentaro and Akiba, Hiroki and Tsutsui, Yuya and Kamada, Haruhiko and Ohno, Hiroaki},
  title = {Design Strategy of Antibody Pairs for Biepitopic Antigen‐Templated Chemical Reaction Depending on the Tertiary Structure of the Antigen},
  journal = {Chemistry – A European Journal},
  year = {2025},
  doi = {10.1002/chem.202501803}
}
Kostenlos starten →